A Functional Roadmap for Clinical Immunotherapy: Early Human Evidence of Recoverable T-Cell Dysfunction

Many of the questions that now shape immunotherapy, including why chronically stimulated T cells fail and whether that failure can be reversed, were anticipated in functional studies of human disease decades before the relevant molecules were known. Between 1992 and 1996, studies of HIV infection and of an experimental model of allergic airway disease used functional assays to show that antigen- specific T-cell responses declined with disease stage and could be partly restored ex vivo by interleukin-2 (IL-2), and that allergen-specific Th2 memory was associated with eosinophilic inflammation and impaired lung function. The HIV studies foreshadowed, and described independently in humans, the loss of antigen-specific T-cell function now termed exhaustion, at around the time it was first described in mice. This Perspective places that work alongside the contributions that led to checkpoint blockade, adoptive cell therapy and anti-IL-5 biologics, and argues that a function-first approach remains a useful guide for adaptive immunotherapy.

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-11-16
DOI
https://doi.org/10.5281/zenodo.24270208
Primary Topic
T-cell and B-cell Immunology
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

A Functional Roadmap for Clinical Immunotherapy: Early Human Evidence of Recoverable T-Cell Dysfunction

Stephen John Duncan Bell
1 links
Zenodo (CERN European Organization for Nuclear Research)
T-cell and B-cell Immunology
preprint

A Functional Roadmap for Clinical Immunotherapy: Early Human Evidence of Recoverable T-Cell Dysfunction

Stephen John Duncan Bell
preprint en

Abstract

Many of the questions that now shape immunotherapy, including why chronically stimulated T cells fail and whether that failure can be reversed, were anticipated in functional studies of human disease decades before the relevant molecules were known. Between 1992 and 1996, studies of HIV infection and of an experimental model of allergic airway disease used functional assays to show that antigen- specific T-cell responses declined with disease stage and could be partly restored ex vivo by interleukin-2 (IL-2), and that allergen-specific Th2 memory was associated with eosinophilic inflammation and impaired lung function. The HIV studies foreshadowed, and described independently in humans, the loss of antigen-specific T-cell function now termed exhaustion, at around the time it was first described in mice. This Perspective places that work alongside the contributions that led to checkpoint blockade, adoptive cell therapy and anti-IL-5 biologics, and argues that a function-first approach remains a useful guide for adaptive immunotherapy.

Zenodo (CERN European Organization for Nuclear Research)
Good health and well-being
T-cell and B-cell Immunology
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon